|
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma |
|
|
|
Titel: |
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma |
Auteur: |
Burke, John M. Shustov, Andrei Essell, James Patel-Donnelly, Dipti Yang, Jay Chen, Robert Ye, Wei Shi, Wen Assouline, Sarit Sharman, Jeff |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 18 (2018) nr. 8 pagina's e327-e331 |
Jaar: |
2018 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|